The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study
Color Therapy
2 other identifiers
interventional
60
1 country
1
Brief Summary
This study was conducted to examine the effect of color therapy on depression, stress, anxiety and quality of life in hemodialysis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 11, 2025
CompletedFirst Posted
Study publicly available on registry
March 17, 2025
CompletedMarch 17, 2025
March 1, 2025
8 months
March 11, 2025
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Depression Anxiety Stress-21 scale (DASS-21)
The 21-question DASS scale used in the study was taken by Henry and Crawford. This scale (DASS-21) has 7 questions each to measure the dimensions of depression, stress and anxiety. The scale is a 4-point Likert-type scale, coded as 0 "not applicable to me", 1 "somewhat applicable to me", 2 "generally applicable to me", and 3 "completely applicable to me".
8 week
Short Form-12 (SF-12) Quality of Life Scale
Ware et al. decided to develop a more practical form of the SF-36 that could be administered in a shorter time and developed the SF-12, which contains the same sub-dimensions as the SF-36 by reducing the number of questions. In addition to the fact that the SF-12 was created in such a way that the same component summary scores can be obtained as the SF-36, the fact that it contains fewer items and therefore has a shorter administration time provides a great advantage. Although it has been demonstrated that the SF-36 scale has sufficient validity and reliability in studies conducted in both patient and normal sample groups in our country, the validity and reliability study of the Turkish form of the SF-12, which was developed as a shorter alternative to the SF-36, was attempted. Similar to SF-36, SF-12 consists of 8 sub-dimensions and 12 items including physical functioning (2 items), physical role (2 items), body pain (1 item), general health (1 item), energy (1 item), social function
8 week
Study Arms (2)
Color therapy group
EXPERIMENTALgroup doing color therapy
No color therapy group
NO INTERVENTIONgroup not doing color therapy
Interventions
In the experimental group, color therapy was applied 3 days a week for the first two weeks, while no intervention was performed in the third and fourth weeks. In the fifth and seventh weeks, color therapy was applied for 15 minutes each day, while no intervention was performed in the sixth week.
Eligibility Criteria
You may qualify if:
- Be on hemodialysis treatment for at least 6 months,
- No sleeping pills or sedative medication,
- No physical or cognitive impairment that prevents them from understanding the education and no diagnosis of a psychiatric illness,
- The patient or someone living in the same household with the patient is literate,
- Patients have no vision problems,
- Patients must be 18 years of age or older.
You may not qualify if:
- Being on hemodialysis treatment for less than 6 months,
- Taking sleeping pills or sedative medication,
- Being diagnosed with a physical illness or cognitive impairment or psychiatric illness that prevents understanding the education provided,
- Illiteracy of the patient and relatives,
- Patients have vision problems,
- Refusing to participate in the research,
- Under 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fırat University
Elâzığ, Merkez, 23119, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gülcan Bahçecioğlu Turan, Associate Professor
Firat University
- STUDY DIRECTOR
Zülfünaz Özer, Associate Professor
Istanbul Sebahattin Zaim University
- STUDY DIRECTOR
Safiye Yanmış, Assistant Professor
Erzincan Binali Yildirim Universitesi
- STUDY DIRECTOR
Mukadder Mollaoğlu, Professor Doctor
Cumhuriyet University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 11, 2025
First Posted
March 17, 2025
Study Start
April 1, 2024
Primary Completion
December 1, 2024
Study Completion
February 1, 2025
Last Updated
March 17, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
After the article is published